MDCX
Medicus Pharma Ltd. Common StockNASDAQ
Healthcare • Drug Manufacturers - General
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Quality Profile
$3.28-8.38%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -48.1%
- 3 months
- -76.8%
- 1 year
- -96.6%
- 52-week range
- $0.09$3.58
- Dividend
- No dividends on record
- Short interest
- 3.7M sharessettled Sep 30, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if MDCX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
3 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
21 filers reported a long position in MDCX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Interchange Capital Partners, LLC | $718.4K | 1.6M | -4.5% |
| JANE STREET GROUP, LLC | $148.9K | 333.7K | New |
| XTX Topco Ltd | $108.6K | 243.4K | New |
| Sterling Investment Advisors, Ltd. | $44.6K | 100K | New |
| COMMONWEALTH EQUITY SERVICES, LLC | $23.5K | 52.6K | +9.3% |
| May Hill Capital, LLC | $22.6K | 50.6K | Unchanged |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14K | 31.5K | New |
| STIFEL FINANCIAL CORP | $13.4K | 30K | New |
| JPMORGAN CHASE & CO | $12.5K | 25.6K | New |
| Wilmington Savings Fund Society, FSB | $11.4K | 25.6K | -50% |
Get the Full Analysis for MDCX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.